Shi Yue, University of Southern California, United States Updates Copyright 2017 Diotallevi, Checconi, Palamara, Celestino, Coppo, Holmgren, Abbas, Peyrot, Mengozzi and Ghezzi
Receptor recovery is actively occurring during this window
Our clinical team can determine B12 deficiency through a blood test and administer a potent dose if necessary
These are not comparable treatments
Phase 2 trial data indicate that the most common side effects are gastrointestinal including nausea, vomiting, diarrhoea, and constipation particularly during dose escalation, which is consistent with other GLP-1-containing therapies
But if the question extends to energy homeostasis, feeding behavior, or the interplay between GH and metabolic state, that appetite signal becomes the most valuable variable in the study